An update of recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults, issued by members of the Joint Task Force on Practice Parameters (JTFPP), changes initial ...

The FDA has approved azelastine HCI and fluticasone propionate nasal spray (Dymista, Meda) to treat seasonal allergic rhinitis. The approval comes after several clinical studies involving more than ...

Allergic rhinitis (AR) is a pervasive health burden affecting over 400 million individuals globally, presenting with a wide ...

Discover a study showing how nasal saline irrigation boosts symptom relief and quality of life in moderate-to-severe allergic rhinitis.

Please provide your email address to receive an email when new articles are posted on . Early sublingual immunotherapy reduces patient-years compared with patients who start it later. Early initiation ...

The global rhinitis market is witnessing steady growth, fueled by increased awareness about respiratory health and innovative treatment options. The introduction of novel intranasal corticosteroids, ...

About one in three pregnant women experience a stuffy nose caused by hormonal changes and increased blood flow.

Please provide your email address to receive an email when new articles are posted on . Researchers called this the first study among children aged 1 to 4 years. The treatment group saw improved ...

Glenmark Pharmaceuticals' subsidiary has received approval from China's National Medical Products Administration for RYALTRIS nasal spray, designed to treat allergic rhinitis. This approval marks a ...

Glenmark Pharmaceuticals Ltd on Monday said its arm Glenmark Specialty SA has received approval from China's National Medical ...

Dr. Anne Lowery explains some of the advancements in treatment options for common ENT conditions. Sponsored by Proliance ENT.